publication venue for
- Radiolabeled products in rat liver and serum after administration of antibody-amide-DTPA-indium-111.. 19. 1992
- Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies.. 18. 1991
- A clinical comparison of bone imaging agents.. 17. 1990
- Differential cellular catabolism of 111In, 90Y and 125I radiolabeled T101 anti-CD5 monoclonal antibody.. 17. 1990
- In vivo stability of ferric hydroxide macroaggregates (FHMA). Is it a suitable carrier for radionuclides used in synovectomy?. 17. 1990
- Anti-murine antibody response to mouse monoclonal antibodies: clinical findings and implications.. 16. 1989
- Comparison of bone marrow dosimetry and toxic effect of high dose 131I-labeled monoclonal antibodies administered to man.. 16. 1989
- Advantages of radioiodine over radioindium labeled monoclonal antibodies for imaging solid tumors.. 15. 1988
- Radiolabeled monoclonal antibody B72.3 localization in metastatic lesions of colorectal cancer patients.. 14. 1987
- Simultaneous estimation of liquid and solid gastric emptying using radiolabelled egg and water in supine normal subjects.. 13. 1986
- Therapeutic applications of radiolabelled antibodies: current situation and prospects.. 13. 1986
- Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides. 1991
- In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung. 1989
- Targeted radiotherapy and immunotherapy of human neuroblastoma with GD2 specific monoclonal antibodies. 1989
- Tumor targeting with monoclonal antibody B72.3. 1989